Skip to main content
Log in

Effect of Increased Extracellular Ca++ on Microvesicle Production and Tumor Spheroid Formation

  • Original Paper
  • Published:
Cancer Microenvironment

Abstract

Research on the composition of the tumor micro-environment has demonstrated that membrane delimited microvesicles are shed from many types of malignant tumors, in the peripheral blood of cancer patients as well as in culture media of tumor cells propagated in vitro (Ginestra et al. Anticancer Res 18:3433–3437, 1998). Their documented effects involve the activation of signal transduction pathways by cellular cross-talk that are associated with epigenetic mechanisms that may be important in tumor progression, metastasis, and the activation of angiogenesis (Distler et al. Arthritis Rheum 52:3337–3348, 2005). Live cell imaging microscopic studies conducted in our laboratory of the formation of solid tumor spheroids in vitro show that the shedding of microvesicular structures from tumor cells occurs during this process. The observed properties of the tumor microvesicles suggest a role in solid tumor formation and intercellular communication. The tumor associated microvesicles were shown to be non-apoptotic based on the absence of fluorescent nuclear staining by acridine orange/ethidium bromide staining. Increased concentration of extracellular Ca++ [5–20 mM] resulted in an increase in the production of tumor-derived microvesicles and also to result in the formation of tumor spheroids whose size was considerably smaller than controls. Increased extracellular [Ca++] was also observed to induce the rapid dissociation of solid tumor spheroids to smaller cell aggregates in the absence of significant apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Ginestra A, LaPlaca MD, Saladino F et al (1998) The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18:3433–3437

    PubMed  CAS  Google Scholar 

  2. Distler JH, Pisetsky DS, Huber LC et al (2005) Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 52:3337–3348

    Article  PubMed  CAS  Google Scholar 

  3. Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13:269–288

    Article  PubMed  CAS  Google Scholar 

  4. Beaudoin AR, Grondin G (1991) Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim Biophys Acta 10:171–203

    Google Scholar 

  5. Horstman LL, Jimenez JJ, Bidot C, Ahn YS (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53:210–230

    Article  PubMed  CAS  Google Scholar 

  6. Skog J, Wurdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–1476

    Article  PubMed  CAS  Google Scholar 

  7. Muralidharan-Chari V, Clancy J, Sedgwick A et al (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611

    Article  PubMed  CAS  Google Scholar 

  8. Valenti R, Huber V, Manuela I et al (2006) Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67:2912

    Article  Google Scholar 

  9. Tl W (2005) Tumor-derived exosomes or microvesicles: another mechanism of tumor escape from the host immune system? Br J Cancer 92:209–211

    Article  Google Scholar 

  10. George JN, Thoi LL, McManus LM et al (1982) Isolation of human membrane microparticles from plasma and serum. Blood 60:834

    PubMed  CAS  Google Scholar 

  11. Yu X, Harris SL, Levine AJ (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66:4795–4801

    Article  PubMed  CAS  Google Scholar 

  12. Ginestra A, Miceli D, Dolo V et al (1999) Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19:3439–3446

    PubMed  CAS  Google Scholar 

  13. DiVizio D, Kim J, Hager M et al (2009) Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69:5601–5609

    Article  CAS  Google Scholar 

  14. Vidulescu C, Clejan S, O’Connor KC (2004) Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells. J Cell Mol Med 8:388–396, 14

    Article  PubMed  Google Scholar 

  15. Janoska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:3143–3149

    Google Scholar 

  16. Barry OP, Fitzgerald GA (1999) Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 82:794–800

    PubMed  CAS  Google Scholar 

  17. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 8:177–184

    Article  Google Scholar 

  18. Francia G, Green S, Kerbel R (2005) Epigenetic aspects of environmentally mediated “multicellular” drug resistance. Am Assoc Cancer Res Educ Book, pp 114–118

  19. Espina V, Mariani B, Gallgher R et al (2010) Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS ONE 5:e10240

    Article  PubMed  Google Scholar 

  20. DeRoos M, van der Vegt B, de Vries J et al (2007) Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 14:2097–2104, 20

    Article  Google Scholar 

  21. Stewart AF (2005) Hypercalcemia associated with cancer. N Engl J Med 352:373–379, 21

    Article  PubMed  CAS  Google Scholar 

  22. Hotte S, Hirte H, Rabbani S, Carling T, Hendy G, Major P (2002) Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment. Am J Cancer 1:179–187

    Article  Google Scholar 

  23. Davidson TG (2001) Conventional treatment of hypercalcemia of malignancy. Am J Health-Syst Pharm 15:S8–S15, 23

    Google Scholar 

  24. Sidler B, Alpert L, Henderson JE, Deckelbaum R, Amizuka N, Silva JE, Goltzman D, Karaplis AC (1996) Amplification of the parathyroid hormone-related peptide gene in a colonic carcinoma. J Clin Endocrinol Metab 81:2841–2847

    Article  PubMed  CAS  Google Scholar 

  25. Anderson J, Grabowska A, Watson S (2007) PTHrP increases transcriptional activity of the integrin subunit α 5. Br J Cancer 96:1394–1403

    PubMed  CAS  Google Scholar 

  26. Suva LJ, Winslow GA, Wettenhall RE et al (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–896

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah Crawford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crawford, S., Diamond, D., Brustolon, L. et al. Effect of Increased Extracellular Ca++ on Microvesicle Production and Tumor Spheroid Formation. Cancer Microenvironment 4, 93–103 (2011). https://doi.org/10.1007/s12307-010-0049-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12307-010-0049-0

Keywords

Navigation